The -582A>G variant of the HAMP promoter is not associated with high serum ferritin levels in normal subjects

Haematologica

Volumn 95, Issue 5, 2010, Pages 849-850

  Bruno, Francesca ^a   Bonalumi, Sara ^a,d   Camaschella, Clara ^a,b   Ferrari, Maurizio ^a,b,c   Cremonesi, Laura ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c Diagnostica e Ricerca San Raffaele   (Italy)

^d Eurand International SpA   (Italy)

Author keywords

Hamp gene; Serum ferritin

Indexed keywords

FERRITIN; HEPCIDIN;

CONTROLLED STUDY; DNA SEQUENCE; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HUMAN; IRON OVERLOAD; LETTER; MALE; NORMAL HUMAN; NUCLEIC ACID BASE SUBSTITUTION; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANTIMICROBIAL CATIONIC PEPTIDES; FERRITINS; GENE FREQUENCY; GENETIC VARIATION; HUMANS; IRON OVERLOAD; MALE; PROMOTER REGIONS, GENETIC;

EID: 77952304008     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.018986     Document Type: Letter

References (7)

1. Andreani M, Radio FC, Testi M, De Bernardo C, Troiano M, Majore S, et al. Association of hepcidin promoter c.-582 A>G variant and iron overload in thalassemia major. Haematologica. 2009;94(9):1293-6.
2. http://www.ncbi.nlm.nih.gov/projects/SNP/.
3. Bayele HK, McArdle H, Srai SK. Cis and transregulation of hep- cidin expression by upstream stimulatory factor. Blood. 2006;108(13):4237-45.
4. Bayele HK, Srai SK. Genetic variation in hepcidin expression and its implications for phenotypic differences in iron metabolism. Haematologica. 2009;94(9):1185-8.
5. De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, et al. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience. Haematologica. 2004;89(10):1161-7.
6. Foglieni B, Cremonesi L, Travi M, Giambona A, Rosatelli MC, Perra C, et al. Beta-thalassemia microelectronic chip: a fast and accurate method for mutation detection. Clin Chem. 2004; 50(1):73-9.
7. Biasiotto G, Roetto A, Daraio F, Polotti A, Gerardi GM, Girelli D, et al. Identification of new mutations of hepcidin and hemojuvelin in patients with HFE C282Y allele. Blood Cells Mol Dis. 2004;33(3):338-43.